Scientists used CRISPR technology to disable the cholesterol gene in a groundbreaking study, though widespread availability remains years away.

After a heart attack, the heart struggles to recoup and maintain energy. One-third of patients develop heart failure as a ...

In the latest close session, CRISPR Therapeutics AG (CRSP) was down 5.44% at $49.93. This move lagged the S&P 500's daily loss of 0.08%. On the other hand, the Dow registered a loss of 0.61%, and the ...

Cathie Wood’s ARK Invest added to several beaten-down technology and biotech names while trimming positions elsewhere. The investment manager made a notable purchase in gene-editing company CRISPR ...

Cathie Wood’s ARK Invest made more than $10 million in trades on March 12, 2026, according to the firm’s daily disclosures.

Imagine biting into a tomato that smells like freshly buttered popcorn. Research published in the journal KeAi showed the world’s first tomato plants with a popcorn-like aroma made using gene-editing ...

Detailed price information for Crispr Therapeutics Ag (CRSP-Q) from The Globe and Mail including charting and trades.

Researchers have used mouse models to study how cocaine addiction alters the brain, illuminating why relapse is common as ...

Emerging research in cellular reprogramming, gene editing, and regenerative medicine is driving interest in preventive ...

Preparing for UPSC Prelims? Important Science & Technology topics include ISRO missions, biotechnology, defence tech, AI, quantum computing, renewable energy.

ARK Invest deployed over $10M in CRISPR Therapeutics and PayPay Corp on March 12, while cutting positions in Teradyne and Ionis Pharmaceuticals.